Regenerative medicine: from new insights to new applications

Call: Regenerative medicine: from new insights to new applications

Logo

Programme

Horizon 2020

Acronym

H2020

Type of Fund

Action programme

Description of programme
"Horizon 2020"

Horizon 2020 is the biggest EU Research and Innovation programme with nearly 80 billion € of funding available over 7 years (2014 to 2020). Apart from classic research projects, Horizon 2020 also funds innovation projects and pilot-projects in different fields.

The programme is divided into three different sections:

Excellent Science
Industrial Leadership
Societal Challenges

Countries eligible for funding are: The EU-Member States, Iceland, Norway, Albania, Bosnia and Herzegovina, the former Yugoslav Republic of Macedonia, Montenegro, Serbia, Turkey, Moldova, Switzerland, Ukraine, Faroe Islands, Israel, Tunisia, Georgia, Armenia.

Link

Link to Programme

Description of programme
"Health, Demographic Change and Wellbeing"

Responding to the challenge of an aging population, research and innovation (R&I) under Horizon 2020 is an investment in better health for all. It aims to keep older people active and independent for longer and supports the development of new, safer and more effective interventions. R&I under Horizon 2020 also contributes to the sustainability of health and care systems.

Call

Regenerative medicine: from new insights to new applications

Description of call
"Regenerative medicine: from new insights to new applications"

Regenerative medicine offers hope for untreatable disease and the ageing population, improved quality of life and reduced medical costs. However, so far, regenerative medicine has not yet proved itself in the clinic beyond rare diseases or conditions of limited public health importance. With recent scientific discoveries opening up new approaches to regenerative medicine, the challenge is to use these to extend the regenerative approach to major diseases and conditions.

Regenerative medicine replaces or regenerates human cells, tissue or organs, to restore or establish normal function. Projects should focus on innovative translational research to develop regenerative processes towards the ultimate clinical goal of addressing unmet clinical needs of large patient groups.

Link

Link to Call

Thematic Focus

Health, Research, Innovation

Funding area

EU Member States
Albania / Shqipëria
Bosnia and Herzegovina
Former Yugoslav Republic of Macedonia / поранешна југословенска Република Македонија
Iceland / Ísland
Moldova
Montenegro / Crna Gora/Црна Гора
Norway / Norge
Serbia / Сpбија
Switzerland / Schweiz / Suisse / Svizzera
Turkey / Türkiye
Ukraine / Україна Oukraïna
Others

Origin of Applicant

Eligible applicants

Education and Training Centres, Federal State / Region / City / Municipality / Local Authority, Research Institution, Lobby Group / Professional Association / Trade Union, International Organization, Small and Medium Sized Enterprises, SMEs (between 10 and 249 employees), Microenterprises (fewer than 10 employees), NGO / NPO, University, Enterprise (more than 250 employees or not defined), Association

Applicant details

All legal entities located in the EU or in Third Countries can participate in Horizon 2020.

Project Partner

Yes

Project Partner Details

As a principle all projects (except coordination and support activities) must comprise at least 3 partners from at least 3 EU Member States or other eligible countries.

Call opens

26.07.2018

Call closes

16.04.2019

Type of Funding

Grant

Financial details

Total call-budget: 50 million €
Indicative budget per project: 6-8 million €
Co-financing rate: max. 100%

Submission

Online via Participant Portal

Contact Details

Link to the National Contact Point Finder.